Abstract:In this study, we have investigated 6 novel influenza‐derived peptides predicted to be restricted to the understudied HLA‐B*18:01 molecule. We identified that 3/6 of the novel peptides were immunogenic in samples from several donors and restricted to HLA‐B*18:01 as predicted and were further characterised. Objectives Seasonal influenza viruses cause roughly 650 000 deaths annually despite available vaccines. CD8+ T cells typically recognise influenza‐derived peptides from internal structural and non‐structural influenza proteins and are an attractive avenue for future vaccine design as they could reduce the severity of disease following infection with diverse influenza strains. CD8+ T cells recognise peptides presented by the highly polymorphic Human Leukocyte Antigens class I molecules (HLA‐I). Each HLA‐I variant has distinct peptide binding preferences, representing a significant obstacle for designing vaccines that elicit CD8+ T cell responses across broad populations. Consequently, the rational design of a CD8+ T cell‐mediated vaccine would require the identification of highly immunogenic peptides restricted to a range of different HLA molecules. Methods Here, we assessed the immunogenicity of six recently published novel influenza‐derived peptides identified by mass‐spectrometry and predicted to bind to the prevalent HLA‐B*18:01 molecule. Results Using CD8+ T cell activation assays and protein biochemistry, we showed that 3/6 of the novel peptides were immunogenic in several HLA‐B*18:01+ individuals and confirmed their HLA‐B*18:01 restriction. We subsequently compared CD8+ T cell responses towards the previously identified highly immunogenic HLA‐B*18:01‐restricted NP219 peptide. Using X‐ray crystallography, we solved the first crystal structures of HLA‐B*18:01 presenting immunogenic influenza‐derived peptides. Finally, we dissected the first TCR repertoires specific for HLA‐B*18:01 restricted pathogen‐derived peptides, identifying private and restricted repertoires against each of the four peptides. Conclusion Overall the characterisation of these novel immunogenic peptides provides additional HLA‐B*18:01‐restricted vaccine targets derived from the Matrix protein 1 and potentially the non‐structural protein and the RNA polymerase catalytic subunit of influenza viruses.

The evolution of HLA-B*3501 binding affinity to variable immunodominant NP(418-426) peptides from 1918 to 2009 pandemic influenza A virus: a molecular dynamics simulation and free energy calculation study.

The Evolution of HLA‐B*3501 Binding Affinity to Variable Immunodominant NP418‐426 Peptides from 1918 to 2009 Pandemic Influenza A Virus: A Molecular Dynamics Simulation and Free Energy Calculation Study

Free-energy Simulations Reveal That Both Hydrophobic and Polar Interactions Are Important for Influenza Hemagglutinin Antibody Binding.

Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.

Characterisation of novel influenza‐derived HLA‐B*18:01‐restricted epitopes

Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes

Identification and Analysis of B Cell Epitopes of Hemagglutinin of H1N1 Influenza Virus.

Large-Scale Analysis of B-Cell Epitopes on Influenza Virus Hemagglutinin - Implications for Cross-Reactivity of Neutralizing Antibodies

Molecular Mechanism of the Enhanced Virulence of 2009 Pandemic Influenza A (H1N1) Virus from D222G Mutation in the Hemagglutinin: a Molecular Modeling Study

The Immunodominant Influenza A Virus M158–66Cytotoxic T Lymphocyte Epitope Exhibits Degenerate Class I Major Histocompatibility Complex Restriction in Humans

Evolution Of The Receptor Binding Properties Of The Influenza A(H3n2) Hemagglutinin

Functional Interplay between Hemagglutinin and Neuraminidase of Pandemic 2009 H1N1 from the Perspective of Virus Evolution

Prediction of Hla-A*0201 Restricted Cytotoxic T Lymphocyte Epitopes in Influenza A H1n1 Virus and the Similarity Analysis of These Epitopes with Those Existing in Other Influenza Viruses

Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates

Analysis of the Contrasting Pathogenicities Induced by the D222G Mutation in 1918 and 2009 Pandemic Influenza A Viruses

Punctuated evolution of influenza virus hemagglutinin (A/H1N1) under opposing migration and vaccination pressures

In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses

Integrating influenza antigenic dynamics with molecular evolution

Molecular Dynamics Studies of Human Receptor Molecule in Hemagglutinin of 1918 and 2009 H1N1 Influenza Viruses

Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin

Structural and immunological characterization of the H3 influenza hemagglutinin during antigenic drift